English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Label-free Redox Imaging of Patient-Derived Organoids Using Selective Plane Illumination Microscopy.

MPS-Authors
/persons/resource/persons219232

He,  Jiaye
Max Planck Institute for Molecular Cell Biology and Genetics, Max Planck Society;

/persons/resource/persons219250

Huisken,  Jan
Max Planck Institute for Molecular Cell Biology and Genetics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Favreau, P. F., He, J., Gil, D. A., Deming, D. A., Huisken, J., & Skala, M. C. (2020). Label-free Redox Imaging of Patient-Derived Organoids Using Selective Plane Illumination Microscopy. Biomedical Optics Express, 11(5), 2591-2606. doi:10.1364/BOE.389164.


Cite as: https://hdl.handle.net/21.11116/0000-0008-A2DC-9
Abstract
High-throughput drug screening of patient-derived organoids offers an attractive platform to determine cancer treatment efficacy. Here, selective plane illumination microscopy (SPIM) was used to determine treatment response in organoids with endogenous fluorescence from the metabolic coenzymes NAD(P)H and FAD. Rapid 3-D autofluorescence imaging of colorectal cancer organoids was achieved. A quantitative image analysis approach was developed to segment each organoid and quantify changes in endogenous fluorescence caused by treatment. Quantitative analysis of SPIM volumes confirmed the sensitivity of patient-derived organoids to standard therapies. This proof-of-principle study demonstrates that SPIM is a powerful tool for high-throughput screening of organoid treatment response.